Cascadian Therapeutics - Ownership and Business Overview

Life ScienceCompany

Cascadian Therapeutics Ownership

Who owns Cascadian Therapeutics?

Cascadian Therapeutics is owned by Seagen. It was acquired on January 31, 2018.

Cascadian Therapeutics Business Overview

Where is Cascadian Therapeutics headquartered?

Cascadian Therapeutics is headquartered in Seattle, Washington.

How many employees does Cascadian Therapeutics have?

Cascadian Therapeutics has 57 employees.

What sector is Cascadian Therapeutics in?

Cascadian Therapeutics is a life science company.

When was Cascadian Therapeutics founded?

Cascadian Therapeutics was founded in 1985.

Life Science M&A Summary in 2018

Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2018. The largest life science acquisition in 2018 was Shire - which was acquired by Takeda Pharmaceutical for $67.7B.

Join Mergr to view all 246 acquisitions of life science companies in 2018, including 44 acquisitions by private equity firms, and 202 by strategics.

Cascadian Therapeutics, Inc.

2601 Fourth Avenue, Suite 500,
Seattle, Washington 98121
United States,
(206) 801-2100
www.cascadianrx.com

Cascadian Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to developing innovative product candidates for the treatment of cancer. Cascadian Therapeutics was founded in 1985 and is based in Seattle, Washington.


 Subscribe to unlock this and 209,130
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 202K M&A Transactions
  • 205K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.